Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's Disease Seite 1
22.02.2024 - Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that it has filed a new ... Seite 1
United States Michael Mcfadden Alpha Cognition Alpha Cognition Chart Lpha Cognition Kurs Lpha Cognition Aktie
Source: wallstreet-online.de